Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2011; 17(6): 796-803
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.796
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.796
Table 5 Reverse-transcription polymerase chain reaction showing relative expression levels of RRAS, POMC, SLC26A6 and STX3 (mean ± SD)
| Group | POMC | SLC26A6 | RRAS | STX3 |
| Biliary atresia (n = 40) | 0.58 ± 0.090 | 0.43 ± 0.054 | 0.89 ± 0.103 | 0.61 ± 0.074 |
| Neonatal cholestasis (n = 14) | 0.41 ± 0.081 | 0.30 ± 0.029 | 0.47 ± 0.074 | 0.51 ± 0.045 |
| P-value | 0.031 | 0.023 | 0.004 | 0.017 |
- Citation: Zhao R, Li H, Shen C, Zheng S. RRAS: A key regulator and an important prognostic biomarker in biliary atresia. World J Gastroenterol 2011; 17(6): 796-803
- URL: https://www.wjgnet.com/1007-9327/full/v17/i6/796.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i6.796